ResearchMoz

Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline

GBI Research
Published Date » 2013-07-10
No. Of Pages » 186
   
 GBI Research’s report “Pain Management Therapeutics Market to 2019 Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline“ provides insights and analysis into the market. Pain is a widespread problem across the world. More than 25% of the total population suffers from some clinically significant pain in a year. Since pain considerably affects day-to-day activities in life, its management presents a considerable challenge for physicians. Inadequate pain control remains a major problem across the world. There is an urgent and unmet need to manage these pain-related problems accurately. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In many cases, such as cancer...
Table of Contents

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 13

2 Pain Management Therapeutics Market to 2019 - Introduction 16

3 Pain Management Therapeutics Market to 2019 - Market Overview 17
3.1 Introduction 17
3.2 World Health Organization Pain Ladder 18
3.3 Risk Evaluation and Mitigation Strategy 19
3.4 Revenue 20
3.5 Major Marketed Pain Management Drugs 21
3.5.1 Abstral (fentanyl citrate) 21
3.5.2 Celebrex (celecoxib) 22
3.5.3 Cymbalta (duloxetine) 23
3.5.4 Exparel (Bupivacaine ER) 24
3.5.5 Lidoderm (lidocaine patch) 25
3.5.6 Lyrica (pregabalin) 26
3.5.7 Nucynta ER (tapentadol ER) 27
3.5.8 Qutenza (capsaicin) 28
3.5.9 Savella (milnacipran hydrochloride) 29
3.5.10 Vimovo (esomeprazole magnesium + naproxen) 30
3.5.11 Voltaren Gel (diclofenac sodium) 31
3.6 Annual Cost of Therapy 32
3.7 Treatment Usage Patterns 33
3.7.1 Prevalence Population 34
3.7.2 Diagnosed Population 34
3.7.3 Prescription Population 34
3.8 Drivers and Restraints of the Pain Management Therapeutics Market 35
3.8.1 Drivers 35
3.8.2 Restraints 36

4 Pain Management Therapeutics Market to 2019 - Therapeutic Landscape 37
4.1 Pain Management Therapeutics Market for Fibromyalgia 37
4.1.1 Introduction 37
4.1.2 Revenue 37
4.1.3 Annual Cost of Therapy 39
4.1.4 Treatment Flow Algorithm 40
4.1.5 Treatment Usage Pattern 41
4.1.6 Geographical Segmentation 43
4.1.7 Drivers and Restraints for the Fibromyalgia Market 44
4.1.8 Drivers 45
4.1.9 Restraints for the Fibromyalgia Pain Relief Market 45
4.2 Pain Management Therapeutics for Neuropathic Pain 46
4.2.1 Introduction 46
4.2.2 Revenue 46
4.2.3 Annual Cost of Therapy 48
4.2.4 Treatment Flow Algorithm 49
4.2.5 Treatment Usage Pattern 50
4.2.6 Geographical Segmentation 52
4.2.7 Drivers and Restraints for the Neuropathic Pain Market 53
4.2.8 Drivers 53
4.2.9 Restraints 54
4.3 Pain Management Therapeutics Market for Migraine 55
4.3.1 Introduction 55
4.3.2 Revenue 55
4.3.3 Annual Cost of Therapy 57
4.3.4 Treatment Flow Algorithm 58
4.3.5 Treatment Usage Pattern 59
4.3.6 Geographical Segmentation 61
4.3.7 Drivers and Restraints for the Migraine Market 62
4.3.8 Drivers 62
4.3.9 Restraints 62
4.4 Pain Management Therapeutics Market for Cancer Pain 63
4.4.1 Introduction 63
4.4.2 Revenue 64
4.4.3 Annual Cost of Therapy 65
4.4.4 Treatment Flow Algorithm 66
4.4.5 Treatment Usage Pattern 67
4.4.6 Geographical Segmentation 69
4.4.7 Drivers and Restraints for the Cancer Pain Market 70
4.4.8 Drivers 70
4.4.9 Restraints 71
4.5 Pain Management Therapeutics Market for Osteoarthritis Pain 72
4.5.1 Introduction 72
4.5.2 Revenue 72
4.5.3 Annual Cost of Therapy 74
4.5.4 Treatment Flow Algorithm 75
4.5.5 Treatment Usage Pattern 76
4.5.6 Geographical Segmentation 78
4.5.7 Drivers and Restraints for the Osteoarthritis Pain Market 79
4.5.8 Drivers 79
4.5.9 Restraints 79
4.6 Pain Management Therapeutics Market for Rheumatoid Arthritis Pain 80
4.6.1 Introduction 80
4.6.2 Revenue 80
4.6.3 Annual Cost of Therapy 82
4.6.4 Treatment Flow Algorithm 83
4.6.5 Treatment Usage Pattern 84
4.6.6 Geographical Segmentation 86
4.6.7 Drivers and Restraints for the Rheumatoid Arthritis Market 87
4.6.8 Drivers 87
4.6.9 Restraints 87
4.7 Pain Management Therapeutics Market for Low Back Pain 88
4.7.1 Introduction 88
4.7.2 Revenue 88
4.7.3 Annual Cost of Therapy 90
4.7.4 Treatment Flow Algorithm 91
4.7.5 Treatment Usage Pattern 92
4.7.6 Geographical Segmentation 94
4.7.7 Drivers and Restraints for the Low Back Pain Market 95
4.7.8 Drivers 95
4.7.9 Restraints 95
4.8 Pain Management Therapeutics Market for Post-operative Pain 96
4.8.1 Introduction 96
4.8.2 Revenue 97
4.8.3 Annual Cost of Therapy 98
4.8.4 Treatment Flow Algorithm 99
4.8.5 Treatment Usage Pattern 100
4.8.6 Geographical Segmentation 102
4.8.7 Drivers and Restraints for the Post-operative Pain Market 103
4.8.8 Drivers 103
4.8.9 Restraints 103

5 Pain Management Therapeutics Market to 2019 - Geographical Landscape 104
5.1 The US 105
5.1.1 Revenue 105
5.1.2 Annual Cost of Therapy 106
5.1.3 Treatment Usage Pattern 107
5.2 Top Five European Countries 109
5.2.1 Revenue 109
5.2.2 Annual Cost of Therapy 110
5.2.3 Treatment Usage Pattern 111
5.3 Japan 113
5.3.1 Revenue 113
5.3.2 Annual Cost of Therapy 114
5.3.3 Treatment Usage Pattern 115

6 Pain Management Therapeutics Market to 2019 - Asia-Pacific and China 117
6.1 India 117
6.1.1 Regulatory Landscape 117
6.1.2 Marketed Products 120
6.1.3 Company Profiling 121
6.2 China 125
6.2.1 Regulatory Landscape 125
6.2.2 Marketed Products 128
6.2.3 Company Profiling 128
6.3 Australia 129
6.3.1 Regulatory Landscape 129
6.3.2 Marketed Products 130
6.3.3 Company Profiling 131

7 Pain Management Therapeutics Market to 2019 - Pipeline Analysis 134
7.1 Introduction 134
7.1.1 Research and Development Pipeline – Fibromyalgia 136
7.1.2 Research and Development Pipeline – Neuropathic Pain 138
7.1.3 Research and Development Pipeline – Migraine 143
7.1.4 Research and Development Pipeline – Cancer Pain 146
7.1.5 Research and Development Pipeline – Osteoarthritis Pain 148
7.1.6 Research and Development Pipeline – Low Back Pain 150
7.1.7 Research and Development Pipeline – Post-operative Pain 152
7.2 Profiles of Key Late-Stage Drugs in the Pain Management Therapeutics Market 154
7.2.1 AmiKet 154
7.2.2 Civanex 155
7.2.3 Droxidopa 156
7.2.4 Posidur 157
7.2.5 Sativex 158
7.2.6 TNX-102 159
7.2.7 Tetrodotoxin 160

8 Pain Management Therapeutics Market to 2019 - Competitive Landscape 161
8.1 Pfizer Inc 161
8.1.1 Overview 161
8.1.2 Product Profile 161
8.2 Johnson & Johnson 162
8.2.1 Overview 162
8.2.2 Product Portfolio 162
8.3 Endo Pharmaceuticals 163
8.3.1 Overview 163
8.3.2 Product Portfolio 163
8.4 Forest Laboratories 164
8.4.1 Overview 164
8.4.2 Product Portfolio 164
8.5 Eli Lilly 164
8.5.1 Overview 164
8.5.2 Product Portfolio 165
8.6 Teva Pharmaceuticals (Cephalon, Inc.) 165
8.6.1 Overview 165
8.6.2 Product Portfolio 165
8.7 Purdue Pharma 166
8.7.1 Overview 166
8.7.2 Product Portfolio 166

9 Pain Management Therapeutics Market to 2019 - Strategic Consolidations 168
9.1 Overview 168
9.1.1 M&A Deals by Year 168
9.1.2 M&A Deals by Indication 169
9.1.3 Recent Deals 170
9.2 Licensing Agreements 171
9.2.1 Deals by Year 171
9.2.2 Deals by Indication 172
9.2.3 Deals by Phase 173
9.2.4 Recent Licensing Deals 174
9.3 Partnership Deals 175
9.3.1 Deals by Year 175
9.3.2 Deals by Indication 176
9.3.3 Recent Partnership Deals 177

10 Management Therapeutics Market to 2019 - Appendix 178
10.1 Market Definitions 178
10.2 Abbreviations 178
10.3 Bibliography 180
10.4 Research Methodology 182
10.4.1 Coverage 182
10.4.2 Secondary Research 182
10.4.3 Primary Research 183
10.5 Therapeutic Landscape 183
10.5.1 Market 185
10.6 Geographical Landscape 186
10.7 Pipeline Analysis 186
10.8 Competitive Landscape 186
10.8.1 Expert Panel Validation 186
10.9 Contact Us 186
10.10 Disclaimer 186

List of Tables


Table 1: Pain Management Therapeutics Market, Top Seven Markets, Revenue ($bn), 2006–2012 20
Table 2: Pain Management Therapeutics Market, Top Seven Markets, Revenue Forecast ($bn), 2012–2019 20
Table 3: Pain Management Therapeutics Market, Top Seven Markets, Annual Cost of Therapy ($), 2006–2012 32
Table 4: Pain Management Therapeutics Market, Top Seven Markets, Annual Cost of Therapy Forecast ($), 2012–2019 32
Table 5: Pain Management Therapeutics Market, Top Seven Markets, Treatment Usage Pattern (million), 2006–2012 33
Table 6: Pain Management Therapeutics Market, Top Seven Markets, Treatment Usage Pattern Forecast (million), 2012–2019 34
Table 7: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Revenue ($bn), 2006–2012 38
Table 8: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Revenue Forecast ($bn), 2012–2019 38
Table 9: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Annual Cost of Therapy ($), 2006–2012 39
Table 10: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Annual Cost of Therapy Forecast ($), 2012–2019 39
Table 11: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Treatment Usage Pattern (Million), 2006–2012 41
Table 12: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Treatment Usage Pattern Forecast (Million), 2012–2019 41
Table 13: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Revenue ($bn), 2006–2012 46
Table 14: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Revenue Forecast ($bn), 2012–2019 47
Table 15: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Annual Cost of Therapy ($), 2006–2012 48
Table 16: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Annual Cost of Therapy Forecast ($), 2012–2019 48
Table 17: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Treatment Usage Pattern (million), 2006–2012 50
Table 18: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Treatment Usage Pattern Forecast (million), 2012–2019 50
Table 19: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Revenue ($bn), 2006–2012 55
Table 20: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Revenue Forecast ($bn), 2012–2019 56
Table 21: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Annual Cost of Therapy ($), 2006–2012 57
Table 22: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Annual Cost of Therapy Forecast ($), 2012–2019 57
Table 23: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Treatment Usage Pattern (million), 2006–2012 59
Table 24: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Treatment Usage Pattern Forecast (million), 2012–2019 60
Table 25: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Revenue ($bn), 2006–2012 64
Table 26: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Revenue Forecast ($bn), 2012–2019 64
Table 27: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Annual Cost of Therapy ($), 2006–2012 65
Table 28: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Annual Cost of Therapy Forecast ($), 2012–2019e 65
Table 29: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Treatment Usage Pattern (million), 2006–2012 67
Table 30: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Treatment Usage Pattern Forecast (million), 2012–2019 67
Table 31: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Revenue ($bn), 2006–2012 73
Table 32: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Revenue Forecast ($bn), 2012–2019 73
Table 33: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Annual Cost of Therapy ($), 2006–2012 74
Table 34: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Annual Cost of Therapy Forecast ($), 2012–2019 74
Table 35: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Treatment Usage Pattern (million), 2006–2012 76
Table 36: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Treatment Usage Pattern Forecast (million), 2012–2019 76
Table 37: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Revenue ($bn), 2006–2012 80
Table 38: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Revenue Forecast ($bn), 2012–2019 81
Table 39: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Annual Cost of Therapy ($’000), 2006–2012 82
Table 40: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Annual Cost of Therapy Forecast ($’000), 2012–2019 82
Table 41: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Treatment Usage Pattern (million), 2006–2012 84
Table 42: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Treatment Usage Pattern Forecast (million), 2012–2019 84
Table 43: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Revenue ($bn), 2006–2012 89
Table 44: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Revenue Forecast ($bn), 2012–2019 89
Table 45: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Annual Cost of Therapy ($), 2006–2012 90
Table 46: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Annual Cost of Therapy Forecast ($), 2012–2019 90
Table 47: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Treatment Usage Pattern (million), 2006–2012 92
Table 48: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Treatment Usage Pattern Forecast (million), 2012–2019 93
Table 49: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Revenue ($bn), 2006–2012 97
Table 50: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Revenue Forecast ($bn), 2012–2019 97
Table 51: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Annual Cost of Therapy ($), 2006–2012 98
Table 52: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Annual Cost of Therapy Forecast ($), 2012–2019 98
Table 53: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Treatment Usage Pattern Forecast (million), 2006–2012 100
Table 54: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Treatment Usage Pattern Forecast (million), 2012–2019 100
Table 55: Pain Management Therapeutics Market, US, Revenue ($bn), 2006–2012 105
Table 56: Pain Management Therapeutics Market, US, Revenue Forecast ($bn), 2012–2019 105
Table 57: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2006–2012 106
Table 58: Pain Management Therapeutics Market, US, Annual Cost of Therapy Forecast ($), 2012–2019 106
Table 59: Pain Management Therapeutics Market, US, Treatment Usage Pattern (million), 2006–2012 107
Table 60: Pain Management Therapeutics Market, US, Treatment Usage Pattern Forecast (million), 2012–2019 107
Table 61: Pain Management Therapeutics Market, Top Five European Countries, Revenue ($bn), 2006–2012 109
Table 62: Pain Management Therapeutics Market, Top Five European Countries, Revenue Forecast ($bn), 2012–2019 109
Table 63: Pain Management Therapeutics Market, Top Five European Countries, Annual Cost of Therapy ($), 2006–2012 110
Table 64: Pain Management Therapeutics Market, Top Five European Countries, Annual Cost of Therapy Forecast ($), 2012–2019 110
Table 65: Pain Management Therapeutics Market, Top Five European Countries, Treatment Usage Pattern (million), 2006–2012 111
Table 66: Pain Management Therapeutics Market, Top Five European Countries, Treatment Usage Pattern Forecast (million), 2012–2019 111
Table 67: Pain Management Therapeutics Market, Japan, Revenue ($bn), 2006–2019 113
Table 68: Pain Management Therapeutics Market, Japan, Revenue Forecast ($bn), 2006–2019 113
Table 69: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2006–2012 114
Table 70: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy Forecast ($), 2012–2019 114
Table 71: Pain Management Therapeutics Market, Japan, Treatment Usage Pattern (million), 2006–2012 115
Table 72: Pain Management Therapeutics Market, Japan, Treatment Usage Pattern Forecast (million), 2012–2019 115
Table 73: Pain Management Therapeutics Market, India, Marketed Products, 2013 120
Table 74: Cipla, India, Marketed Products, 2013 121
Table 75: Sun Pharmaceuticals, India, Marketed Products, 2013 122
Table 76: Zydus Cadila, India, Marketed Products, 2013 123
Table 77: Lupin, India, Marketed Products, 2013 124
Table 78: Pain Management Therapeutics Market, China, Marketed Products, 2013 128
Table 79: Pain Management Therapeutics Market, China, Xian Janssen Marketed Products, 2013 128
Table 80: Xian Janssen, China, Marketed Products, 2013 129
Table 81: Pain Management Therapeutics Market, Australia, Marketed Products, 2013 130
Table 82: Alphapharm, Australia, Marketed Products, 2013 131
Table 83: Apotex, Australia, Marketed Products, 2013 132
Table 84: Aspen, Australia, Marketed Products, 2013 133
Table 85: Pain Management Therapeutics Market, Global, Fibromyalgia R&D Pipeline by Phase (%), 2013 137
Table 86: Pain Management Therapeutics Market, Global, Neuropathic Pain R&D Pipeline by Phase, 2013 139
Table 87: Pain Management Therapeutics Market, Global, Migraine R&D Pipeline by Phase (%), 2013 144
Table 88: Pain Management Therapeutics Market, Global, Cancer Pain R&D Pipeline by Phase, 2013 147
Table 89: Pain Management Therapeutics Market, Global, Osteoarthritis Pain R&D Pipeline by Phase (%), 2013 149
Table 90: Pain Management Therapeutics Market, Global, Low Back Pain R&D Pipeline by Phase, 2013 151
Table 91: Pain Management Therapeutics Market, Global, Post-operative Pain R&D Pipeline by Phase, 2013 153
Table 92: Pain Management Therapeutics Market, Global, Recent M&A Deals, 2011–2013 170
Table 93: Pain Management Therapeutics Market, Global, Recent Licensing Agreements, 2011–2013 174
Table 94: Pain Management Therapeutics Market, Global, Recent Partnership Deals, 2011–2013 177

List of Figures


Figure 1: Pain Management Therapeutics Market, Top Seven Markets, Revenue by Indication (%), 2012 17
Figure 2: Pain Management Therapeutics Market, WHO Three-Step Ladder for Pain Management, 2013 18
Figure 3: Pain Management Therapeutics Market, Opioids – Adverse Effects, 2013 19
Figure 4: Pain Management Therapeutics Market, Top Seven Markets, Revenue Forecast ($bn), 2006–2019 20
Figure 5: Pain Management Therapeutics Market, Top Seven Markets, Annual Cost of Therapy Forecast ($), 2006–2019 32
Figure 6: Pain Management Therapeutics Market, Top Seven Markets, Treatment Usage Pattern Forecast (million), 2006–2019 33
Figure 7: Pain Management Therapeutics Market, Drivers and Restraints, 2013 35
Figure 8: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Revenue Forecast ($bn), 2006–2019 37
Figure 9: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Annual Cost of Therapy Forecast ($), 2006–2019 39
Figure 10: Pain Management Therapeutics Market, Global, Fibromyalgia, Treatment Algorithm, 2013 40
Figure 11: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Treatment Usage Pattern Forecast (million), 2006–2019 41
Figure 12: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Segmentation by Geography (%), 2012 43
Figure 13: Pain Management Therapeutics Market, Fibromyalgia, Drivers and Restraints, 2013 44
Figure 14: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Revenue Forecast ($bn), 2006–2019 46
Figure 15: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Annual Cost of Therapy Forecast ($), 2006–2019 48
Figure 16: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Algorithm 49
Figure 17: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Treatment Usage Pattern Forecast (million), 2006–2019 50
Figure 18: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Segmentation by Geography (%), 2012 52
Figure 19: Pain Management Therapeutics Market, Global, Neuropathic Pain Drivers and Restraints, 2013 53
Figure 20: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Revenue Forecast ($bn), 2006–2019 55
Figure 21: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Annual Cost of Therapy Forecast ($), 2006–2019 57
Figure 22: Pain Management Therapeutics Market, Global, Migraine, Treatment Algorithm 58
Figure 23: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Treatment Usage Pattern Forecast (million), 2006–2019 59
Figure 24: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Segmentation by Geography (%), 2012 61
Figure 25: Pain Management Therapeutics Market, Migraine, Drivers and Restraints, 2013 62
Figure 26: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Revenue Forecast ($bn), 2006–2019 64
Figure 27: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Annual Cost of Therapy Forecast ($), 2006–2019 65
Figure 28: Pain Management Therapeutics Market, Global, Cancer Pain, Treatment Algorithm 66
Figure 29: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Treatment Usage Pattern Forecast (million), 2006–2019 67
Figure 30: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Segmentation by Geography (%), 2012 69
Figure 31: Pain Management Therapeutics Market, Global, Cancer Pain, Drivers and Restraints, 2013 70
Figure 32: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Revenue Forecast ($bn), 2006–2019 72
Figure 33: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Annual Cost of Therapy Forecast ($), 2006–2019 74
Figure 34: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Algorithm 75
Figure 35: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Treatment Usage Pattern Forecast (million), 2006–2019 76
Figure 36: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Segmentation by Geography (%), 2012 78
Figure 37: Pain Management Therapeutics Market, Global, Osteoarthritis Pain, Drivers and Restraints, 2013 79
Figure 38: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Revenue Forecast ($bn), 2006–2019 80
Figure 39: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Annual Cost of Therapy Forecast ($’000), 2006–2019 82
Figure 40: Pain Management Therapeutics Market, Global, Rheumatoid Arthritis Pain, Treatment Algorithm 83
Figure 41: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Treatment Usage Pattern Forecast (million), 2006–2019 84
Figure 42: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Segmentation by Geography (%), 2012 86
Figure 43: Pain Management Therapeutics Market, Global, Rheumatoid Arthritis Pain Drivers and Restraints, 2013 87
Figure 44: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Revenue Forecast ($bn), 2006–2019 88
Figure 45: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Annual Cost of Therapy Forecast ($), 2006–2019 90
Figure 46: Pain Management Therapeutics Market, Global, Low Back Pain, Treatment Algorithm 91
Figure 47: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Treatment Usage Pattern Forecast (million), 2006–2019 92
Figure 48: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Segmentation by Geography (%), 2012 94
Figure 49: Pain Management Therapeutics Market, Global, Low Back Pain Drivers and Restraints, 2013 95
Figure 50: Pain Management Therapeutics Market, WFSA Three-step Ladder for Pain Management 96
Figure 51: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Revenue Forecast ($bn), 2006–2019 97
Figure 52: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Annual Cost of Therapy Forecast ($), 2006–2019 98
Figure 53: Pain Management Therapeutics Market, Global, Post-operative Pain Treatment Algorithm 99
Figure 54: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Treatment Usage Pattern Forecast (million), 2006–2019 100
Figure 55: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Segmentation by Geography (%), 2012 102
Figure 56: Pain Management Therapeutics Market, Global, Post-operative Pain Drivers and Restraints, 2013 103
Figure 57: Pain Management Therapeutics Market, Top Seven Markets, Market Share by Geography (%), 2012 104
Figure 58: Pain Management Therapeutics Market, US, Revenue Forecast ($bn), 2006–2019 105
Figure 59: Pain Management Therapeutics Market, US, Annual Cost of Therapy Forecast ($), 2006–2019 106
Figure 60: Pain Management Therapeutics Market, US, Treatment Usage Pattern Forecast (million), 2006–2019 107
Figure 61: Pain Management Therapeutics Market, Top Five European Countries, Revenue Forecast ($bn), 2006–2019 109
Figure 62: Pain Management Therapeutics Market, Top Five European Countries, Annual Cost of Therapy Forecast ($), 2006–2019 110
Figure 63: Pain Management Therapeutics Market, Top Five European Countries, Treatment Usage Pattern Forecast (million), 2006–2019 111
Figure 64: Pain Management Therapeutics Market, Japan, Revenue Forecast ($bn), 2006–2019 113
Figure 65: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy Forecast ($), 2006–2019 114
Figure 66: Pain Management Therapeutics Market, Japan, Treatment Usage Pattern Forecast (million), 2006–2019 115
Figure 67: Pain Management Therapeutics Market, India, Intellectual Property Rights Protection Framework, 2011 117
Figure 68: Pain Management Therapeutics Market, India, Regulatory Landscape, Intellectual Property Rights Protection, 1963–2005 118
Figure 69: Pain Management Therapeutics Market, Global, R&D Pipeline by Indication (%), 2013 134
Figure 70: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase (%), 2013 135
Figure 71: Pain Management Therapeutics Market, Global, Fibromyalgia R&D Pipeline by Phase (%), 2013 136
Figure 72: Pain Management Therapeutics Market, Global, Neuropathic Pain R&D Pipeline by Phase (%), 2013 138
Figure 73: Pain Management Therapeutics Market, Global, Migraine R&D Pipeline by Phase (%), 2013 143
Figure 74: Pain Management Therapeutics Market, Global, Cancer Pain R&D Pipeline by Phase (%), 2013 146
Figure 75: Pain Management Therapeutics Market, Global, Osteoarthritis Pain R&D Pipeline by Phase (%), 2013 148
Figure 76: Pain Management Therapeutics Market, Global, Low Back Pain R&D Pipeline by Phase (%), 2013 150
Figure 77: Pain Management Therapeutics Market, Global, Post-operative Pain R&D Pipeline by Phase (%), 2013 152
Figure 78: Pain Management Therapeutics Market, Global, Number of M&A Deals by Year, 2007–2013 168
Figure 79: Pain Management Therapeutics Market, Global, M&A Deals by Indication (%),2007–2013 169
Figure 80: Pain Management Therapeutics Market, Global, Number of Licensing Deals by Year, 2007–2013 171
Figure 81: Pain Management Therapeutics Market, Global, Licensing Agreements by Indication (%), 2007–2013 172
Figure 82: Pain Management Therapeutics Market, Global, Licensing Agreements by Phase (%), 2007–2013 173
Figure 83: Pain Management Therapeutics Market, Global, Number of Partnership Deals by Year, 2007–2013 175
Figure 84: Pain Management Therapeutics Market, Global, Co-Development Deals by Indication (%), 2007–2013 176
Figure 85: GBI Research Market Forecasting Model 185

Upcoming Reports:

Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal anti-inflammatory drugs. Although COX-2 is used in treatment of RA, it has several side effects associated with the upper gastrointestinal region.  Currently, use of disease modifying antirheumatic drugs is recommended by most professionals in the early stages of disease. ...
Propanol Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Propanol is a colorless chemical found mostly in two forms, viz., n-propanol and iso propanol. Propanol is manufactured by hydration of propylene and acetone hydrogenation. Iso-propanol is an isomer of propanol and mainly used in pharmaceutical applications as a solvent and for manufacturing of different chemicals. n-propanol is used widely in coating, printing, and ink industry and as a direct solvent. Major application of propanol is solvent and this segment is categorized as coating solvent, process solvent, aerosol solvent and cleaning agent. Propanol is precursor of...
Transparent Electronics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Transparent electronics is an emerging technology that focuses on producing optoelectronic devices and invisible electronic circuitry.  It conducts transparent conducting oxides (TCO) such as In2O3, SnO2, ZnO, and CdO. Transparent electronics dramatically change the use and look of electronic devices. They increase the potential of innovative products by adding features like the ability to display information on an automobile windshield or surfing the Web on top of a tea table. In the last decade, the market for different materials used in transparent electronic applications has...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...